» Articles » PMID: 33015211

Three-dimensional, Scaffold-Free, Autologous Chondrocyte Transplantation: A Systematic Review

Overview
Specialty Orthopedics
Date 2020 Oct 5
PMID 33015211
Citations 8
Authors
Affiliations
Soon will be listed here.
Abstract

Background: A 3-dimensional, scaffold-free, and completely autologous form of chondrocyte transplantation (ACT3D) has been developed and applied in clinical practice in the past decade to overcome disadvantages of previous-generation procedures.

Purpose: To document and analyze the available literature on the results of ACT3D in the treatment of articular chondral lesions in the knee and hip joints.

Study Design: Systematic review; Level of evidence, 4.

Methods: All studies published in English addressing ACT3D were identified and included those that fulfilled the following criteria: (1) level 1 through 4 evidence, (2) measures of radiological or functional/clinical outcome, and (3) outcome related to cartilage lesions of the knee and hip joints.

Results: A total of 10 studies were selected: 2 randomized controlled trials, 1 cohort study, and 7 case series. The studies revealed significant increases in patients' subjective quality of life, satisfaction, pain reduction, and improvement in joint function at short- to medium-term follow-up. Magnetic resonance imaging-assisted examination and second-look arthroscopy showed a hyaline-like repair tissue with a high degree of defect filling and integration.

Conclusion: ACT3D shows promising results in the therapy of articular cartilage defects in the knee as well as in the hip, but well-designed, long-term studies are lacking. ACT3D might have relevant advantages over common matrix-associated autologous chondrocyte transplantation products, but systematic evaluation and randomized controlled studies are crucial to verify the potential of this tissue-engineered approach.

Citing Articles

Charting a quarter-century of commercial cartilage regeneration products.

Liu X, Guo X, Pei Y, Pei M, Ge Z J Orthop Translat. 2025; 50:354-363.

PMID: 39968336 PMC: 11833628. DOI: 10.1016/j.jot.2024.10.009.


Polydeoxynucleotide-Loaded Visible Light Photo-Crosslinked Gelatin Methacrylate Hydrogel: Approach to Accelerating Cartilage Regeneration.

Park S, Son Y, Park J, Lee S, Kim N, Jang S Gels. 2025; 11(1).

PMID: 39852013 PMC: 11765300. DOI: 10.3390/gels11010042.


Management of chondral and osteochondral lesions of the hip : A comprehensive review.

Itha R, Vaishya R, Vaish A, Migliorini F Orthopadie (Heidelb). 2023; 53(1):23-38.

PMID: 37815635 PMC: 10781822. DOI: 10.1007/s00132-023-04444-9.


Cartilage Defect Treatment Using High-Density Autologous Chondrocyte Implantation (HD-ACI).

Guillen-Garcia P, Guillen-Vicente I, Rodriguez-Inigo E, Guillen-Vicente M, Fernandez-Jaen T, Navarro R Bioengineering (Basel). 2023; 10(9).

PMID: 37760185 PMC: 10525711. DOI: 10.3390/bioengineering10091083.


Nanomedicine and regenerative medicine approaches in osteoarthritis therapy.

Goudarzi R, Dehpour A, Partoazar A Aging Clin Exp Res. 2022; 34(10):2305-2315.

PMID: 35867240 DOI: 10.1007/s40520-022-02199-5.


References
1.
Fickert S, Schattenberg T, Niks M, Weiss C, Thier S . Feasibility of arthroscopic 3-dimensional, purely autologous chondrocyte transplantation for chondral defects of the hip: a case series. Arch Orthop Trauma Surg. 2014; 134(7):971-8. DOI: 10.1007/s00402-014-1997-5. View

2.
Siebold R, Karidakis G, Feil S, Fernandez F . Second-look assessment after all-arthroscopic autologous chondrocyte implantation with spheroides at the knee joint. Knee Surg Sports Traumatol Arthrosc. 2015; 24(5):1678-85. DOI: 10.1007/s00167-015-3822-2. View

3.
Trattnig S, Pinker K, Krestan C, Plank C, Millington S, Marlovits S . Matrix-based autologous chondrocyte implantation for cartilage repair with HyalograftC: two-year follow-up by magnetic resonance imaging. Eur J Radiol. 2005; 57(1):9-15. DOI: 10.1016/j.ejrad.2005.08.006. View

4.
Niemeyer P, Laute V, Zinser W, John T, Becher C, Diehl P . Safety and efficacy of matrix-associated autologous chondrocyte implantation with spheroid technology is independent of spheroid dose after 4 years. Knee Surg Sports Traumatol Arthrosc. 2020; 28(4):1130-1143. DOI: 10.1007/s00167-019-05786-8. View

5.
Vadala G, Russo F, Musumeci M, DEste M, Cattani C, Catanzaro G . Clinically relevant hydrogel-based on hyaluronic acid and platelet rich plasma as a carrier for mesenchymal stem cells: Rheological and biological characterization. J Orthop Res. 2016; 35(10):2109-2116. DOI: 10.1002/jor.23509. View